Medicine
Vecamyl 2.5 mg tablet
Vecamyl 2.5 mg tablet is a prescription medicine containing Mecamylamine for oral use, marketed by TILDE Sciences, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F) excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Mecamylamine
- Brand
- Vecamyl
- Strength
- 2.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets
- Marketing authorisation holder
- TILDE Sciences
- Manufacturers
- TILDE SciencesVyera Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F) excursions permitted to 15°C to 30°C (59°F to 86°F) Distributed by: Vyera Pharmaceuticals, LLC New York, NY 10016 7183 Rev. 07/18
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C02BB01 Mecamylamine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 19 March 2013
- Identifiers
- RxCUI 1298874, 1373008DailyMed set ID 0774cc48-7287-4093-91d6-9df41a81408a, 0b149023-f7a8-442d-ac69-295df8e66ed3NDC 69413-558, 83649-558Application ANDA204054
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 83649-558-01 | TILDE Sciences | 20 February 2025 |
| 100 tablet in 1 bottle | 69413-558-40 | Vyera Pharmaceuticals | 19 March 2013 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 1 March 1956 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Mecamylamine is an autonomic ganglionic blocker. It is available as tablets for oral use. MedsAcross supplies Mecamylamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MecamylamineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Vecamyl prescribing information (TILDE Sciences) · U.S. National Library of Medicine, DailyMed
Need Vecamyl 2.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.